Alpha 1-antichymotrypsin

From WikiMD's WELLNESSPEDIA

Alpha 1-antichymotrypsin (also known as SERPINA3) is a protein that in humans is encoded by the SERPINA3 gene. It is a member of the serpin superfamily of proteins, which function as serine protease inhibitors. Alpha 1-antichymotrypsin is primarily produced in the liver and secreted into the bloodstream, where it plays a crucial role in the body's immune response.

Function[edit]

Alpha 1-antichymotrypsin inhibits the activity of certain enzymes, such as cathepsin G and mast cell chymase, that are released during inflammation. By doing so, it helps to limit tissue damage and promote healing. It also forms a complex with alpha-1 antitrypsin, another serpin, to inhibit the proteolytic activity of neutrophil elastase, a key enzyme involved in the body's immune response.

Clinical significance[edit]

Alterations in the SERPINA3 gene or the alpha 1-antichymotrypsin protein can lead to a variety of health conditions. For example, elevated levels of alpha 1-antichymotrypsin have been associated with Alzheimer's disease, chronic obstructive pulmonary disease (COPD), and certain types of cancer. In Alzheimer's disease, alpha 1-antichymotrypsin is found in high concentrations in the amyloid plaques that characterize the disease.

Research[edit]

Research into alpha 1-antichymotrypsin is ongoing, with scientists seeking to better understand its role in health and disease. This includes studying its potential as a biomarker for certain conditions, as well as exploring ways to target it for therapeutic purposes.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.